Basic and applied research have historically been rather uncomfortable bedfellows, but biotechnology is one area where progress from concept to application can be staggeringly fast. Less than 10 years ago researchers were pondering how to sequence large tracts of DNA reasonably quickly, yet today Celera has a market capitalization of close to $1 billion for doing just that. Facilitating crossover from basic to applied research is now high on the agendas of governments in most developed countries.
Japan is seen by many as the home of applied research but what is less well publicised is how its goverment tries to ease the transition to the applied arena. When I went to work in Japan almost 10 years ago, I hoped to witness this at first hand. The job I took was at a research institute jointly funded by MITI (Ministry of International Trade and Industry) and several chemical and pharmaceutical companies. The institute was, in fact, set up as a company that had a fixed lifetime, an approach to funding that was first used when Japan was playing catch-up with the US in silicon chip technology.
In the mid-1970s, MITI encouraged five electronics companies to pool their knowledge of chip technology in a limited-lifetime joint company, by providing around $100 million of additional government funding. The project began in 1976 and the results were so staggering that by the early 1980s Japan led the rest of the world in VLSI (very large scale integration) chip technology.
There are now many such research insitutes in Japan. Each institute is set up as an independent company with an enormous reserve of cash to use within a 5-8 year timespan. But even in Japan, money doesn't guarantee results. Materially, the institutes are great places to work but, as you might expect, they can be complicated politically. Furthermore, although I can only speak about those institutes in the biological sciences, none of these have produced results anywhere near as significant as those of the original VLSI project.
Even in Japan, money doesn't guarantee results

Why does this model seem not to have lived up to its original promise?
The first problem is lack of focus. I know of no institute since the chip project that has been set up with such clear objectives. The two I worked at were involved with protein engineering and cDNA sequencing. Protein engineering is an enormous field and, even after it had been split up into five research groups the institute lacked focus. The cDNA technology institute had the potential to be more directed but the research groups spread themselves too thinly in an effort to please all the participating companies and the government. (It is perhaps ironic that a simpler high-throughput facility dedicated solely to sequencing, would have ultimately captured the current mood much better.)
This lack of focus also complicates the recruitment of personnel. If the area to be covered is large, there are unlikely to be enough experienced employees in any of the participating companies. For this reason, these institutes also recruit promising young Japanese researchers (particularly those doing postdocs abroad) to be staff scientists, and supplement this further with a postdoc scheme. This tends to be a recipe for disaster in many ways, but particularly when group leaders from the industrial sector have less senior, yet able, scientists from academia below them. Interactions between group leaders from academia and industry can also be exciting.
Publication is another tricky subject. Although researchers from these institutes do publish their work, there is a clear difference between the urgency of the academics -who regard publication as their lifeblood (after the fixed life of the institute they may well have to move back into academia) -and the view of those from MITI, who see success in terms of patents obtained.
These institutes are awash with money, yet all of it is pre-allocated before a single researcher is recruited, with a lot going on hardware. The salaries of direct employees are paid at government rates. This would be just about acceptable if they did not then have to work with company personnel who are on much higher rates. Innumerable times I was asked why more foreigners do not come to work in Japan. The simple answer is that a country that is not seen as a hot spot for career progression, and has a cost of living second to none has to do something to tempt researchers to its shores. Competitive salaries and reasonable accomodation would be a good starting point.
I reluctantly left Japan in 1998, having been there for seven years. Why did I stay so long? I did not go to Japan for career progression and was quite happy just to find a job there in the first instance. During my stay I was lucky enough to progress from being a postdoc at my first MITI institute to being a company employee at the second. I was able to avoid most politics and could concentrate on working with the many talented researchers that I met. Who knows how long I might have stayed if those institutes were better set up to fulfill their great potential.
